Open AccessDrug Coated Balloon Angioplasty in Peripheral Vasculature: Review of Literature
Author(s) -
Valerie F Civelli
Publication year - 2019
Publication title -
clinical cardiology and cardiovascular interventions
Language(s) - English
Resource type - Journals
ISSN - 2641-0419
DOI - 10.31579/2641-0419/034
Subject(s) - angioplasty , restenosis , medicine , arterial disease , balloon , paclitaxel , atherectomy , peripheral , surgery , vascular disease , stent , radiology , chemotherapy
Drug-coated balloons (DCB) are commonly used to treat peripheral artery disease (PAD) and are often used in combination with or in place of a stent or rotational atherectomy. DCB’s are manufactured with the drug, Paclitaxel with the first-line indication of preventing restenosis of arteries following an intervention. Recent literature has suggested an increased mortality risk at years 2 and 5 post DCB angioplasty. Inspired by Katsanos et al. and their important work in researching outcomes for DCBs in PAD, we conducted a thorough review of all literature to compile an informed conclusion.